Photobiomodulation Explained: The Science Behind Red Light Therapy

Table of Contents

    Quick Answer

    Photobiomodulation is the use of specific wavelengths of red and near-infrared light to stimulate cellular activity, primarily by activating mitochondria to produce more ATP. The light is absorbed by an enzyme called cytochrome c oxidase, which triggers a cascade of effects including increased circulation, reduced inflammation, and accelerated tissue repair. It is the scientific mechanism behind red light therapy.

    Red light therapy gets called a lot of things. The mask, the wand, the panel, the "NASA tech," the wellness trend. The actual science underneath all of it has one name: photobiomodulation. If you have ever wondered what is happening inside your skin when an LED face mask sits on top of it for 10 minutes, this is the answer.

    This guide covers what photobiomodulation does at the cellular level, which wavelengths matter and why, what the research supports, and what it cannot do. No marketing claims, no shortcuts on the biology.

    Illustration of red and near-infrared light penetrating skin to reach mitochondria, the cellular site of photobiomodulation

    The One-Line Definition

    Photobiomodulation, often shortened to PBM, is the use of low-power red and near-infrared light to stimulate biological activity in living cells. The light is not hot, does not contain ultraviolet rays, and does not damage tissue. Instead, it is absorbed by specific molecules inside your cells that respond by producing more energy and triggering downstream repair processes.

    You may also see it called low-level laser therapy (LLLT), low-level light therapy, or simply red light therapy. The terminology has evolved, but the underlying mechanism is the same.

    How Light Becomes Cellular Energy

    The mechanism is more specific than "light helps cells." Here is what actually happens.

    Inside every one of your cells are organelles called mitochondria. Mitochondria produce adenosine triphosphate (ATP), the molecule your cells use as energy. Embedded in the inner membrane of each mitochondrion is an enzyme called cytochrome c oxidase, which sits at the end of the electron transport chain that generates most of your ATP.

    Cytochrome c oxidase has a peak absorption for light in the red and near-infrared range, specifically around 670nm and 830nm. When red or near-infrared photons hit the enzyme, researchers have proposed that the light dissociates inhibitory nitric oxide from the enzyme, restoring electron transport and increasing the mitochondrial membrane potential. The cell produces more ATP as a result.

    More ATP means the cell has more energy to do its normal work, including repair. Secondary effects include a brief, controlled increase in reactive oxygen species (which acts as a signaling molecule), a rise in nitric oxide (which improves local circulation), and modulation of calcium levels inside the cell. Tertiary effects show up over time and include activation of transcription factors that influence cell survival, proliferation, and the synthesis of new proteins like collagen.

    Cytochrome c oxidase is the most studied site of light absorption, but it is not the only one. Hamblin and colleagues have also documented mechanisms involving heat-gated ion channels and other photoreceptors. The science is still developing.

    Why Specific Wavelengths Matter

    Light therapy works on a narrow band of wavelengths. Most consumer devices use one or more of the following:

    415nm (blue light). Targets acne-causing bacteria (C. acnes) on the skin surface by disrupting their cellular metabolism. Blue light also helps regulate sebum production, which can reduce the oiliness that contributes to breakouts, and has documented anti-inflammatory effects that calm active lesions. Not a true photobiomodulation wavelength in the sense of activating cytochrome c oxidase, but commonly grouped with LED therapy because it shares the device format and addresses a distinct skin concern.

    590nm (yellow light). Targets brightening and skin tone by supporting circulation and lymphatic drainage at the surface level. Yellow light is studied for reducing surface-level inflammation, calming redness associated with rosacea, and helping to fade dark spots and post-inflammatory hyperpigmentation. It penetrates less deeply than red light, staying primarily in the upper dermis, which makes it effective for visible tone and color concerns rather than deep structural change.

    630 to 660nm (red light). The primary skin wavelength. Penetrates 2 to 3mm, reaching the dermis where fibroblasts produce collagen and elastin. This is the wavelength most LED face masks rely on.

    800 to 850nm (near-infrared, or NIR). Penetrates deeper, around 4 to 5cm, reaching muscle and joint tissue. Used in recovery panels and devices designed for body use.

    1072nm (deep near-infrared, sometimes abbreviated as DIR or deep infrared ray). The deepest commercially available wavelength, reaching 6 to 8cm. Used for deep-tissue recovery and the kind of cellular work that surface wavelengths cannot reach.

    Wavelengths outside these bands have less evidence behind them. Pink and purple LEDs in some masks are blends of red and blue rather than true single wavelengths. Cyan and white modes are typically marketing extensions rather than clinically distinct treatments.

    The Depth-of-Penetration Ladder

    Different wavelengths reach different tissue depths. This is why a device for facial skin and a device for muscle recovery use different specs.

    Blue light at 415nm reaches the very top layer of the skin, the epidermis, which is where acne bacteria live. Red light at 630 to 660nm reaches the dermis, the layer where collagen and elastin are produced. Near-infrared at 800 to 850nm passes through skin and reaches muscle, joints, and connective tissue underneath. Deep near-infrared at 1072nm reaches the deepest tissue layers, which is why it shows up in recovery-focused devices rather than skincare masks.

    A device that only emits 630nm is designed for skin. A device that only emits 850nm is designed for body recovery. A device that combines red and near-infrared can do both, with the trade-off that no single wavelength is optimized for any one outcome.

    What Photobiomodulation Is Proven to Support

    The research base is uneven across applications. Some uses have strong evidence, others are still emerging. Here is the honest picture.

    Skin rejuvenation. Red light at 630nm and near-infrared at 830nm have been shown in controlled trials to stimulate collagen production, reduce fine lines, and improve skin tone over 8 to 12 weeks of consistent use. The American Academy of Dermatology notes that more than 90% of patients in one study reported some skin improvement after 8 sessions over 4 weeks.

    Wound healing. One of the most established uses, originally documented in the NASA research that brought LED therapy to consumer attention. US Navy LED trials reported faster healing of musculoskeletal injuries and lacerations compared to control groups.

    Muscle recovery. A 2016 review in the Journal of Biophotonics by Ferraresi, Huang, and Hamblin screened dozens of clinical trials and concluded that red and near-infrared light can enhance recovery and performance in both athletes and non-athletes. Subsequent meta-analyses have shown consistent reductions in delayed onset muscle soreness when photobiomodulation is applied before or after exercise.

    Joint pain and stiffness. Evidence is strongest for osteoarthritis. Multiple meta-analyses, including systematic reviews of randomized controlled trials, have found that photobiomodulation reduces pain and morning stiffness in knee osteoarthritis when applied consistently at 660nm and 850nm wavelengths.

    Hair regrowth. The AAD notes that randomized controlled trials have shown some hair regrowth in androgenetic alopecia using low-level laser therapy, leading to FDA clearance for several at-home caps and combs.

    Mood and circadian rhythm. Early-stage research suggests light exposure may support mood and sleep regulation, but consumer claims here often outpace the evidence.

    What Photobiomodulation Is Not

    It is not a cure. It does not reverse advanced structural damage, regenerate cartilage that is gone, or fix conditions that need medical treatment. It supports your cells' existing repair processes. It does not create new ones.

    It is not instant. Most users notice subtle changes in 2 to 4 weeks and visible structural changes at 8 to 12 weeks. If a device claims overnight results, that is marketing.

    It is not unlimited. Photobiomodulation follows a biphasic dose response, which means too little light produces no effect and too much light can produce reduced or even negative effects. More minutes per session does not mean faster results.

    It is not a substitute for sunscreen, sleep, hydration, or anything else fundamental to skin health. It is a layer on top of those.

    NASA LED plant growth experiment in the 1990s, the origin of photobiomodulation research for human health

    From NASA to Your Bathroom Counter

    The modern history of photobiomodulation starts with a plant growth experiment. In the early 1990s, Quantum Devices Inc. developed an LED light source under NASA contracts to grow plants on the Space Shuttle. Conventional grow lights drew too much power and produced too much heat for spacecraft, so red LEDs were tested as an alternative.

    According to NASA's own account of the research, scientists working on the plant experiment noticed that small skin lesions on their hands healed unexpectedly fast under the red light. NASA followed the lead and partnered with Dr. Harry Whelan at the Medical College of Wisconsin to investigate medical applications. Subsequent studies showed accelerated healing of oxygen-deprived wounds in animal models, and US Navy trials reported significant improvements in musculoskeletal injuries and laceration healing times.

    The research expanded over the next two decades into pain, inflammation, hair regrowth, muscle recovery, and skin rejuvenation. Consumer devices arrived in the 2010s, and the term photobiomodulation began replacing "low-level laser therapy" in the academic literature as LEDs became the primary delivery format.

    How to Evaluate a Photobiomodulation Device

    Four specs matter more than anything else on a product page.

    Wavelength. Look for specific numbers, not vague terms like "red light" or "infrared." A credible device lists exact wavelengths such as 630nm, 660nm, 830nm, 850nm, or 1072nm. If a device does not specify wavelength, treat that as a warning sign.

    Irradiance. This is the power output per unit area, measured in milliwatts per square centimeter (mW/cm²). Clinical photobiomodulation protocols typically use 40 to 200 mW/cm². Devices that do not publish irradiance often do not have enough to publish.

    Dose. Dose is irradiance multiplied by time, measured in joules per square centimeter (J/cm²). Most studied protocols use 4 to 60 J/cm² per session. A device with low irradiance may still deliver a useful dose with a longer session, but the math has to work out.

    Safety credentials. In the United States, some consumer photobiomodulation devices obtain FDA 510(k) clearance as Class II devices, which means they have been reviewed for safety. Many reputable devices in this category have not yet completed 510(k) clearance or are currently in the process, because the pathway is lengthy and applies to specific finished devices, not the underlying technology. Outside the US, look for CE marking verified by an independent notified body (not self-declared), which indicates the device meets European safety, health, and quality standards. Compliance with IEC 62471, the international standard for photobiological safety of lamps and lamp systems, is another meaningful signal that the device has been evaluated for safe light exposure levels on skin and eyes. No single credential guarantees efficacy, but a device that carries none of these should raise questions.

    Beyond specs, the device that delivers results is the one you actually use. Dermatologists consistently emphasize that consistency matters more than intensity for at-home use. A comfortable mask used 4 times a week outperforms a powerful one that sits in a drawer.

    Halio's Place in This Conversation

    Halio is one of several brands bringing photobiomodulation into home routines. The product line covers three use cases that map to the wavelengths above.

    The Halio PureGlow Ultralite Silicone LED Face Mask delivers four wavelengths in a single hands-free session: red (630nm) and near-infrared (850nm) for collagen and tissue repair, blue (415nm) for acne and oil control, and yellow (590nm) for brightening and redness. At 93 grams with 216 LEDs across 54 modules, it runs a 10-minute auto-shutoff session that covers the full face simultaneously.

    The Halio Red Light Therapy Device is a handheld wand at 630nm with 16 LEDs, designed for targeted work on specific areas like under-eye wrinkles, smile lines, and the jawline. It combines red light with EMS for muscle toning, sonic vibration for circulation, and gentle warmth at 42°C to enhance skincare absorption. Its 90-degree rotating head adapts to facial contours, and at 63 grams it is small enough for travel use. The Lift & Light Duo pairs the mask and the wand for a complete face routine covering both full-face treatment and targeted precision.

    Halio is also launching a portable recovery panel with three wavelengths: 660nm red, 850nm NIR, and 1072nm deep near-infrared (DIR) for whole-body recovery use, extending the product line from face into body for the first time.

    The science underneath all of these is the same photobiomodulation mechanism described above. The differences come down to wavelength, coverage area, irradiance, and how the form factor fits into your routine.

    FAQ

    What does photobiomodulation actually do at the cellular level?

    Photobiomodulation activates an enzyme called cytochrome c oxidase inside your mitochondria. This increases ATP production, which gives cells more energy to repair themselves. Secondary effects include better local circulation, modulated inflammation, and signaling that supports collagen production and tissue repair over time.

    Is photobiomodulation the same as red light therapy?

    Photobiomodulation is the scientific name for the mechanism. Red light therapy is the consumer name for the practice. They refer to the same thing. You may also see "low-level laser therapy" or LLLT in older research, which describes the same process delivered by laser rather than LED.

    Does photobiomodulation work for everyone?

    Most healthy adults respond to photobiomodulation, but results vary based on age, baseline skin or tissue condition, device specs, and consistency of use. People with certain conditions, including active cancer, photosensitivity, or those taking light-sensitizing medications, should consult a doctor before use. Pregnancy is generally a precautionary exclusion.

    How long do photobiomodulation effects last?

    Skin and tissue changes built up over weeks of consistent treatment can persist for months after stopping, but the effects are not permanent. Collagen production gradually returns to baseline if treatment stops entirely. Most users maintain results with reduced-frequency sessions, often 1 to 2 times per week after the initial 8 to 12 week build phase.

    What wavelengths are used in photobiomodulation?

    The most studied wavelengths are 630 to 660nm (red light, surface skin), 800 to 850nm (near-infrared, deeper tissue), and 1072nm (deep near-infrared). Some devices also include 415nm (blue, for acne) and 590nm (yellow, for redness), though these are not technically the same mechanism as red and near-infrared photobiomodulation.

    Can photobiomodulation hurt you?

    Photobiomodulation at consumer device intensities is widely considered safe. There is no UV exposure, no heat damage, and no documented risk of cumulative harm. Eye protection is recommended for devices used near the face, since bright LED light can cause discomfort or short-term visual disturbance. Following the device's recommended session length avoids the diminishing returns of the biphasic dose response.

    Is photobiomodulation FDA-approved?

    The distinction between FDA-approved and FDA-cleared matters here. FDA approval applies to high-risk Class III medical devices and involves extensive clinical trials. Most consumer photobiomodulation devices are Class II and follow the 510(k) clearance pathway, which reviews safety and substantial equivalence to previously cleared devices. Many credible devices in this category are currently in the 510(k) process or have not pursued clearance because the pathway applies to specific finished devices, not to the underlying LED technology itself. LED light technology has been widely studied in peer-reviewed research independently of any single device. Outside the US, CE marking verified by an independent notified body and compliance with IEC 62471 (photobiological safety) are the primary safety credentials. When evaluating a device, look at the full picture across certifications rather than treating any single credential as a pass-or-fail gate.

    To explore how Halio's devices apply photobiomodulation to skin, face, and body, read more about how red light therapy works.